<DOC>
	<DOCNO>NCT01978535</DOCNO>
	<brief_summary>This study design investigate whether treatment non-anemic iron deficiency intervenous iron sucrose result decrease symptom reporting improve cardiovascular index adolescent ( age 12-21 ) Postural Orthostatic Tachycardia Syndrome ( POTS ) .</brief_summary>
	<brief_title>Iron Sucrose Adolescents With Iron Deficiency Postural Orthostatic Tachycardia Syndrome ( POTS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Postural Orthostatic Tachycardia Syndrome</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Inclusion criterion age 1221 year chronic ( &gt; 3 month ) symptoms orthostatic intolerance ( include limited lightheadedness , syncope , headache , fatigue , weakness , sweat , nausea palpitation ) symptomatic orthostatic heart rate increase great equal 40 beat per minute 10 minute 70 degree head tilt study presence nonanemic iron deficiency , define serum ferritin level less equal 20 ug/L normal hemoglobin Exclusion criterion orthostatic hypotension within 3 minute 70 degree head tilt pregnant lactating female presence organ failure systemic illness affect autonomic function concurrent medication therapy anticholinergic , alphaadrenergic antagonist , betaadrenergic antagonist unless medication hold five halflives prior study laboratory evidence anemia iron overload personal history hematochromatosis first degree relative hematochromatosis know sensitivity Venofer ( TM ) intravenous iron preparation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>POTS</keyword>
</DOC>